the Circle. · DDIF 2027 · London
What compounds.
What translates.
Who reaches the patient.
Less noise. More signal.
01
Every drug discovery leader is asked the same question. How does a hypothesis become a candidate, with data that holds? McKinsey’s September 2026 analysis finds AI-enabled programmes reaching first-in-human milestones 15 to 80 percent faster than large pharma medians. Faster to the clinic. Not yet better in it.
02
The white space is the room that holds the decision differently. Closed-door. By invitation. End-user led. No expo hall. No vendor pitch. A circle for the leaders building what compounds.
03
the Conversation. DDIF is that room. Senior drug discovery leadership convened around the work that translates. Target identification. AI-driven design. Translational science.
04
Who attends. Senior faculty drawn from the leaders who own the portfolio, sign the IND and carry the decision.
Drug Discovery Innovation Forum 2027
For decision makers from small biotech to large pharma.
The gap.
Drug discovery moves faster than the frameworks designed to govern it. AI-driven compound design generates candidates faster than medicinal chemistry can validate. Predictive toxicity models recommend lead optimisation paths no human would have chosen. The gap between algorithmic output and scientific accountability has never been formally named.
The Conversation.
DDIF convenes the leaders building the intelligence that closes that gap · across AI-driven design, automated chemistry and translational science. The corridor where drug discovery ambition becomes clinical candidate · or breaks. The Conversation is where the leaders who carry the decision meet before the portfolio review does.
The decision.
The room holds the decision before the programme locks. For the leaders who own the portfolio, sign the IND and answer for the intelligence layer no one has formally governed.
In the room.
Forum highlights · DDIF 2026 · The Savoy, London.
Uwe Gottschalk.
Operating Partner · Keensight Capital · DDIF 2026 · The Savoy, London.
"
AI alone will not accelerate science.
Christian Olsen · VP Strategy, Protein Therapeutics · Dotmatics Luma · DDIF 2026
the Circle. forum · in the room
ddif.ai · the years before · by GBX Circle
A selection of the organisations whose senior leaders sit in the DDIF circle.
Organisations who have partnered DDIF or whose senior leaders attend.
the circle. · access
The prospectus is not public. It is shared directly with the organisations that belong in the room.
The room. The conversations. The decisions.
A note on privacy.
This site uses essential cookies to function. We optionally use analytics to understand how the site is used. Nothing is shared. Nothing is sold.